Literature DB >> 29369918

Public health impact of androgens.

Gen Kanayama1, Marc J Kaufman, Harrison G Pope.   

Abstract

PURPOSE OF REVIEW: To summarize recent findings regarding the public health impact of androgen abuse. RECENT
FINDINGS: Abuse of androgens (also called 'anabolic-androgenic steroids') has grown into a major worldwide substance abuse problem involving tens of millions of individuals, of whom about 98% are men. Most androgen abusers are still under age 50 today, and thus, the long-term effects of these drugs are only beginning to be understood. Recent studies confirm that long-term supraphysiologic androgen exposure produces cardiovascular toxicity, characterized especially by cardiomyopathy and atherosclerotic disease. Withdrawal from androgens after long-term use may produce prolonged and sometimes irreversible hypogonadism in men. Supraphysiologic androgen levels may sometimes cause irritability, aggressiveness, and violence, whereas androgen withdrawal may cause depression. However, these psychiatric effects are idiosyncratic, affecting only a minority of users. Emerging evidence now also suggests that long-term androgen exposure may cause neurotoxicity, raising the possibility that aging androgen abusers may be at increased risk for dementia. Several recent studies have also described androgen-induced hepatotoxicity, nephrotoxicity, and adverse musculoskeletal effects.
SUMMARY: Recent studies have demonstrated marked adverse effects of long-term androgen abuse. As increasing numbers of androgen abusers reach middle age, these effects will likely represent an emerging public health problem.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29369918      PMCID: PMC6358207          DOI: 10.1097/MED.0000000000000404

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  49 in total

1.  Aggression Is Associated With Increased Anabolic-Androgenic Steroid Use Contemplation Among Adolescents.

Authors:  Dominic Sagoe; Rune A Mentzoni; Daniel Hanss; Ståle Pallesen
Journal:  Subst Use Misuse       Date:  2016-06-29       Impact factor: 2.164

2.  White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study.

Authors:  Johanna Seitz; Amanda E Lyall; Gen Kanayama; Nikos Makris; James I Hudson; Marek Kubicki; Harrison G Pope; Marc J Kaufman
Journal:  Psychiatry Res Neuroimaging       Date:  2016-12-10       Impact factor: 2.376

3.  Anabolic steroid abuse among teenage girls: an illusory problem?

Authors:  Gen Kanayama; Matthew Boynes; James I Hudson; Alison E Field; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2006-11-28       Impact factor: 4.492

4.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

5.  Vasopressin differentially modulates aggression and anxiety in adolescent hamsters administered anabolic steroids.

Authors:  Thomas R Morrison; Lesley A Ricci; Richard H Melloni
Journal:  Horm Behav       Date:  2016-05-03       Impact factor: 3.587

Review 6.  Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.

Authors:  Miren García-Cortés; Mercedes Robles-Díaz; Aida Ortega-Alonso; Inmaculada Medina-Caliz; Raul J Andrade
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

7.  Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion.

Authors:  Dhananjay R Namjoshi; Wai Hang Cheng; Michael Carr; Kris M Martens; Shahab Zareyan; Anna Wilkinson; Kurt A McInnes; Peter A Cripton; Cheryl L Wellington
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

8.  Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.

Authors:  Jon Jarløv Rasmussen; Christian Selmer; Peter Busch Østergren; Karen Boje Pedersen; Morten Schou; Finn Gustafsson; Jens Faber; Anders Juul; Caroline Kistorp
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

9.  Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer's disease.

Authors:  Phetcharat Boonruamkaew; Pennapa Chonpathompikunlert; Long Binh Vong; Sho Sakaue; Yasushi Tomidokoro; Kazuhiro Ishii; Akira Tamaoka; Yukio Nagasaki
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

10.  Brain connectivity aberrations in anabolic-androgenic steroid users.

Authors:  Lars T Westlye; Tobias Kaufmann; Dag Alnæs; Ingunn R Hullstein; Astrid Bjørnebekk
Journal:  Neuroimage Clin       Date:  2016-11-17       Impact factor: 4.881

View more
  8 in total

1.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

2.  Anabolic-androgenic steroids and cognitive effort discounting in male rats.

Authors:  Lisa B Dokovna; Grace Li; Ruth I Wood
Journal:  Horm Behav       Date:  2019-05-08       Impact factor: 3.587

Review 3.  Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.

Authors:  Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana
Journal:  Healthcare (Basel)       Date:  2021-01-19

4.  The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids.

Authors:  Barnaby N Zoob Carter; Ian D Boardley; Katinka van de Ven
Journal:  Front Psychiatry       Date:  2021-03-22       Impact factor: 4.157

5.  When Bodybuilding Goes Wrong-Bilateral Renal Artery Thrombosis in a Long-Term Misuser of Anabolic Steroids Treated with AngioJet Rheolytic Thrombectomy.

Authors:  Artur Lemiński; Markiian Kubis; Krystian Kaczmarek; Adam Gołąb; Arkadiusz Kazimierczak; Katarzyna Kotfis; Marcin Słojewski
Journal:  Int J Environ Res Public Health       Date:  2022-02-14       Impact factor: 3.390

6.  Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2.

Authors:  Mohamed Raafat; Amr A Kamel; Alaa H Shehata; Al-Shaimaa F Ahmed; Asmaa M A Bayoumi; Rabab A Moussa; Mohammed A S Abourehab; Mahmoud El-Daly
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-22

7.  Reliability of Drug History to Verify Androgen Abuse in Men.

Authors:  Nandini Shankara-Narayana; Lance Brooker; Catrin Goebel; Naomi Speers; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

Review 8.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.